Medtronic: Insulin pump therapy more effective than injections
5 December 2006 00:00 in Medical Company Product News
Medtronic has announced the results of a survey it commissioned carried out by GfK Roper Public Affairs regarding the use of insulin pump therapy as an alternative to standard insulin injections for the management of blood glucose levels.
The survey found that both endocrinologists and patients held that insulin pump therapy was a preferable treatment for blood glucose control than injections, with two-thirds of endocrinologists stating that they would choose that form of treatment for themselves or a family member.
Dr Bruce Buckingham, director of paediatric endocrinology at Lucille Packard Children's Hospital reported that hypoglycaemia was a "significant barrier" to the control of diabetes, despite the introduction of longer-acting insulin.
"Insulin pump therapy delivers insulin in patterns similar to how the body delivers insulin," he said.
"This decreases the risk of severe hypoglycaemic events ? allowing patients the flexibility to lead more active, normal lives," he added.
Earlier this week, Medtronic announced its intention to spin-off its external defibrillation business into a new company named Physio-Control. It estimated that this company would have sales of approximately $450 million (227.6 million pounds) in the next financial year.
The new publicly traded and independent company will offer both automated external defibrillators and manual defibrillators that are used by emergency response teams and in hospitals.
Other news stories from 05/12/2006
Read more in the Zenopa News Archive
How this news is generated
Story collated for Zenopa by the Adfero News Agency